Clincosm LogoSign in Get a demo

SPIRIHEMATO: The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality

Sponsor
University Hospital, Limoges (Other)
Overall Status
Unknown status
CT.gov ID
NCT04412135
Collaborator
(none)
10
Enrollment
12
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

The management of patients with malignant hemopathy is based on comprehensive management. In this context and faced with the various difficulties encountered by cancer patients, the question of spirituality and its experience is central. Spirituality refers to the person's attachment to what inspires and gives him foundation, as well as the beliefs, values, and existential experiences associated with it, whether these are religious in nature or not. Although the concept has been identified as a resource in the literature and widely treated in an end-of-life context, assessing the needs of patients with hematological cancer and their loved ones in terms of spirituality from the initiation of treatment does not has not been developed

Condition or Disease Intervention/Treatment Phase
  • Other: spirituality

Study Design

Study Type:
Observational
Anticipated Enrollment :
10 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality During the Initial Healing Phase
Anticipated Study Start Date :
Jun 1, 2020
Anticipated Primary Completion Date :
Feb 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Outcome Measures

Primary Outcome Measures

  1. FACIT-Sp questionnaire [15 minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • Aged ≥ 18 years with a recent diagnosis of hematological cancer (lymphoma or leukemia) and in treatment;

  • Patients who speak and read French;

  • Patients in general condition (physical and mental) judged emotionally and physically fit by the referring nurse to answer the questionnaires;

  • Patients benefiting from a social security scheme,

  • Patients who signed the non-objection form after being informed of the study,

family person:

  • Have been designated by the patient as being the loved one they wish to include with them;

  • Aged ≥ 18 years;

  • Fluent in and reading French;

  • Having signed the non-objection form after being informed of the study.

Exclusion Criteria:

  • Patients in recurrence / progress or in remission of cancer;

  • Patients in the terminal phase of the disease.

Family person:

person in the curative phase of cancer

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Limoges

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Limoges
ClinicalTrials.gov Identifier:
NCT04412135
Other Study ID Numbers:
  • 87RI19_0050
First Posted:
Jun 2, 2020
Last Update Posted:
Jun 2, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Hematologic Neoplasms

Study Results

No Results Posted as of Jun 2, 2020